Genome-wide analyses of ADHD identify 27 risk loci, refine the genetic architecture and implicate several cognitive domainsDitte Demontis, Isabell Brikell, Søren Dalsgaard et al.|Nature Genetics|2023Cited by 755
Attention-Deficit/Hyperactivity Disorder Medications and Long-Term Risk of Cardiovascular DiseasesLe Zhang, Zheng Chang, Lin Li et al.|JAMA Psychiatry|2023Cited by 128
Medication treatment for attention‐deficit/hyperactivity disorder and the risk of acute seizures in individuals with epilepsyIsabell Brikell, Henrik Larsson, Qi Chen et al.|Epilepsia|2019Cited by 52
Attention-deficit/hyperactivity disorder medication and seizuresKelsey K. Wiggs, Brian M. D’Onofrio, Zheng Chang et al.|Neurology|2018Cited by 43
Genetic, Clinical, and Sociodemographic Factors Associated With Stimulant Treatment Outcomes in ADHDIsabell Brikell, Søren Dalsgaard, Theresa Wimberley et al.|American Journal of Psychiatry|2021Cited by 29